Allogeneic hematopoietic stem cell transplantation can cure immune deficiency and immune disorder completely for SCN patients such as cases 2 and 3, and is effective for patients with poor response to G-CSF or combined with MDS/AML. This evidence concerns the gene CSF3 and myelodysplastic syndrome.